Renaissance Technologies

Renaissance Technologies’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Renaissance Technologies’s Portfolio CYTH Stock Details CYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,356	Closed	-$17K	–	3971
2024 Q2	$17K	Sell	13,356 -8,400	-39%	-$11.1K	﹤0.01%	3397
2024 Q1	$30K	Buy	+21,756	New	+$36K	﹤0.01%	3554
2023 Q3	–	Sell	-17,800	Closed	-$28K	–	4202
2023 Q2	$28K	Buy	+17,800	New	+$22.7K	﹤0.01%	3721
2022 Q4	–	Sell	-48,494	Closed	-$94K	–	4483
2022 Q3	$94K	Sell	48,494 -15,492	-24%	-$32.5K	﹤0.01%	3619
2022 Q2	$126K	Sell	63,986 -11,801	-16%	-$28.6K	﹤0.01%	3789
2022 Q1	$240K	Buy	75,787 +9,487	+14%	+$33.2K	﹤0.01%	3569
2021 Q4	$247K	Buy	66,300 +55,818	+533%	+$316K	﹤0.01%	3425
2021 Q3	$71K	Buy	+10,482	New	+$82K	﹤0.01%	3358

Other funds holding CYTH

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $45.5B AUM 21.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return